Ceragenin mediated selectivity of antimicrobial silver nanoparticles

ACS Applied Materials and Interfaces

Volumn 6, Issue 16, 2014, Pages 13900-13908

  Hoppens, Mark A ^a   Sylvester, Christopher B ^a   Qureshi, Ammar T ^a,d   Scherr, Thomas ^b,e   Czapski, Desiree R ^a   Duran, Randolph S ^a   Savage, Paul B ^c   Hayes, Daniel ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Brigham Young University   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

ceragenin; conjugate nanoparticle; selective antimicrobial; specific binding

Indexed keywords

CELL CULTURE; DYNAMIC LIGHT SCATTERING; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MASS SPECTROMETRY; METAL NANOPARTICLES; MICROWAVE INTEGRATED CIRCUITS; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; POLYETHYLENES; ZETA POTENTIAL;

ANTI-MICROBIAL PROPERTIES; ANTIMICROBIAL SILVERS; AVERAGE PARTICLE SIZE; CERAGENIN; HYDRODYNAMIC DIAMETER; MINIMUM INHIBITORY CONCENTRATION; SELECTIVE ANTIMICROBIAL; SPECIFIC BINDING;

SILVER NANOPARTICLES;

ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILVER; STEROID;

CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TEST; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-INFECTIVE AGENTS; ESCHERICHIA COLI; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; SILVER; STAPHYLOCOCCUS AUREUS; STEROIDS;

EID: 84906818512     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am504640f     Document Type: Article

References (43)

1. Guarner, F.; Malagelada, J.-R. Gut Flora in Health and Disease Lancet 2003, 361 (9356) 512-519
2. Kelly, C. P.; Pothoulakis, C.; LaMont, J. T. Clostridium difficile Colitis N. Engl. J. Med. 1994, 330 (4) 257-262
3. Bignardi, G. Risk Factors for Clostridium difficile Infection J. Hosp. Infect. 1998, 40 (1) 1
4. Eckert, R.; He, J.; Yarbrough, D. K.; Qi, F.; Anderson, M. H.; Shi, W. Targeted Killing of Streptococcus mutans by a Pheromone-Guided "Smart" Antimicrobial Peptide Antimicrob. Agents Chemother. 2006, 50 (11) 3651-3657
5. Travan, A.; Pelillo, C.; Donati, I.; Marsich, E.; Benincasa, M.; Scarpa, T.; Semeraro, S.; Turco, G.; Gennaro, R.; Paoletti, S. Non-cytotoxic Silver Nanoparticle-Polysaccharide Nanocomposites with Antimicrobial Activity Biomacromolecules 2009, 10 (6) 1429-1435
6. Pal, S.; Tak, Y. K.; Song, J. M. Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli Appl. Environ. Microbiol. 2007, 73 (6) 1712-1720
7. Yih, T.; Al-Fandi, M. Engineered Nanoparticles as Precise Drug Delivery Systems J. Cell. Biochem. 2006, 97 (6) 1184-1190
8. Minchin, R. F.; Martin, D. J. Minireview: Nanoparticles for Molecular Imaging-An Overview Endocrinology 2010, 151 (2) 474-481
9. Singh, R.; Lillard, J. W., Jr. Nanoparticle-Based Targeted Drug Delivery Exp. Mol. Pathol. 2009, 86 (3) 215-223
10. Gelperina, S.; Kisich, K.; Iseman, M. D.; Heifets, L. The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis Am. J. Respir. Crit. Care Med. 2005, 172 (12) 1487-1490
11. Emerich, D. F.; Thanos, C. G. The Pinpoint Promise of Nanoparticle-Based Drug Delivery and Molecular Diagnosis Biomol. Eng. 2006, 23 (4) 171-184
12. Love, J. C.; Estroff, L. A.; Kriebel, J. K.; Nuzzo, R. G.; Whitesides, G. M. Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology Chem. Rev. 2005, 105 (4) 1103-1170
13. Brown, P. K.; Qureshi, A. T.; Moll, A. N.; Hayes, D. J.; Monroe, W. T. Silver Nanoscale Antisense Drug Delivery System for Photoactivated Gene Silencing ACS Nano 2013, 7 (4) 2948-2959
14. Kim, J. S.; Kuk, E.; Yu, K. N.; Kim, J.-H.; Park, S. J.; Lee, H. J.; Kim, S. H.; Park, Y. K.; Park, Y. H.; Hwang, C.-Y. Antimicrobial Effects of Silver Nanoparticles J. Nanomed. Nanotechnol. 2007, 3 (1) 95-101
15. Lok, C.-N.; Ho, C.-M.; Chen, R.; He, Q.-Y.; Yu, W.-Y.; Sun, H.; Tam, P. K.-H.; Chiu, J.-F.; Che, C.-M. Silver Nanoparticles: Partial Oxidation and Antibacterial Activities J. Biol. Inorg. Chem. 2007, 12 (4) 527-534
16. Baker, T. B.; McFall, R. M.; Shoham, V. Current Status and Future Prospects of Clinical Psychology Toward a Scientifically Principled Approach to Mental and Behavioral Health Care Psychol. Sci. Public Interest 2009, 9 (2) 67-103
17. Aymonier, C.; Schlotterbeck, U.; Antonietti, L.; Zacharias, P.; Thomann, R.; Tiller, J. C.; Mecking, S. Hybrids of Silver Nanoparticles with Amphiphilic Hyperbranched Macromolecules Exhibiting Antimicrobial Properties Chem. Commun. 2002, 24, 3018-3019
18. Gibbins, B.; Warner, L. The Role of Antimicrobial Silver Nanotechnology Med. Device Diagn. Ind. 2005, 1, 1-2
19. Silver, S.; Phung, L. T.; Silver, G. Silver as Biocides in Burn and Wound Dressings and Bacterial Resistance to Silver Compounds J. Ind. Microbiol. Biotechnol. 2006, 33 (7) 627-634
20. Hancock, R.; Patrzykat, A. Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics Curr. Drug Targets: Infect. Disord. 2002, 2 (1) 79-83
21. Zasloff, M. Antimicrobial Peptides of Multicellular Organisms Nature 2002, 415 (6870) 389-395
22. Epand, R. M.; Epand, R. F.; Savage, P. B. Ceragenins (Cationic Steroid Compounds), A Novel Class of Antimicrobial Agents Drug News Perspect. 2008, 21 (6) 307-11
23. Chin, J. N.; Jones, R. N.; Sader, H. S.; Savage, P. B.; Rybak, M. J. Potential Synergy Activity of the Novel Ceragenin, CSA-13, Against Clinical Isolates of Pseudomonas aeruginosa, Including Multidrug-Resistant P. aeruginosa J. Antimicrob. Chemother. 2008, 61 (2) 365-370
24. Leszczyńska, K.; Namiot, A.; Fein, D. E.; Wen, Q.; Namiot, Z.; Savage, P. B.; Diamond, S.; Janmey, P. A.; Bucki, R. Bactericidal Activities of the Cationic Steroid CSA-13 and the Cathelicidin Peptide LL-37 Against Helicobacter pylori in Simulated Gastric Juice BMC Microbiol. 2009, 9 (1) 187
25. Chin, J. N.; Rybak, M. J.; Cheung, C. M.; Savage, P. B. Antimicrobial Activities of Ceragenins Against Clinical Isolates of Resistant Staphylococcus aureus Antimicrob. Agents Chemother. 2007, 51 (4) 1268-1273
26. Leszczyńska, K.; Namiot, D.; Byfield, F. J.; Cruz, K.; Żendzian-Piotrowska, M.; Fein, D. E.; Savage, P. B.; Diamond, S.; McCulloch, C. A.; Janmey, P. A. Antibacterial Activity of the Human Host Defence Peptide LL-37 and Selected Synthetic Cationic Lipids Against Bacteria Associated with Oral and Upper Respiratory Tract Infections Antimicrob. Agents Chemother. 2013, 68 (3) 610-618
27. Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles. In International Committee for Standardization in Haemotology; ASTM International: West Conshohocken, PA, 1979; Vol. E2524-08.
28. Andrews, J. M. Determination of Minimum Inhibitory Concentrations Antimicrob. Agents Chemother. 2001, 48 (Suppl. 1) 5-16
29. Wiegand, I.; Hilpert, K.; Hancock, R. E. Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances Nat. Protoc. 2008, 3 (2) 163-175
30. Seligy, V.; Rancourt, J. Antibiotic MIC/MBC Analysis of Bacillus-Based Commercial Insecticides: Use of Bioreduction and DNA-Based Assays J. Ind. Microbiol. Biotechnol. 1999, 22 (6) 565-574
31. de Nooijer, L. J.; Duijnstee, I.; Van der Zwaan, G. Novel Application of MTT Reduction: A Viability Assay for Temperate Shallow-Water Benthic Foraminifera J. Foraminiferal Res. 2006, 36 (3) 195-200
32. Taylor, P.; Schoenknecht, F.; Sherris, J.; Linner, E. Determination of Minimum Bactericidal Concentrations of Oxacillin for Staphylococcus aureus: Influence and Significance of Technical Factors Antimicrob. Agents Chemother. 1983, 23 (1) 142-150
33. Isenberg, H. D., Ed. Clinical Microbiology Procedures Handbook; ASM Press: Washington, DC, 2007.
34. Perry, J.; Reuter, K. G.; Kai, M. P.; Herlihy, K. P.; Jones, S. W.; Luft, J. C.; Napier, M. E.; Bear, J. E.; DeSimone, J. M. PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics Nano Lett. 2012, 12 (10) 5304-5310
35. Agasti, S. S.; Chompoosor, A.; You, C. C.; Ghosh, P.; Kim, C. K.; Rotello, V. M. Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles J. Am. Chem. Soc. 2009, 131 (16) 5728-5729
36. Chertok, B.; Moffat, B. A.; David, A. E.; Yu, F.; Bergemann, C.; Ross, B. D.; Yang, V. C. Iron Oxide Nanoparticles as a Drug Delivery Vehicle for MRI Monitored Magnetic Targeting of Brain Tumors Biomaterials 2008, 29 (4) 487-496
37. Moghadam, B. Y.; Hou, W. C.; Corredor, C.; Westerhoff, P.; Posner, J. The Role of Nanoparticle Surface Functionality in the Disruption of Model Cell Membranes Langmuir 2012, 28 (47) 16318-16326
38. Brown, P. K.; Qureshi, A. T.; Moll, A. N.; Hayes, D. J.; Monroe, W. T. Silver Nanoscale Antisense Drug Delivery System for Photoactivated Gene Silencing ACS Nano 2013, 7 (4) 2948-2959
39. Ding, B.; Guan, Q.; Walsh, J. P.; Boswell, J. S.; Winter, T. W.; Winter, E. S.; Boyd, S. S.; Li, C.; Savage, P. B. Correlation of the Antibacterial Activities of Cationic Peptide Antibiotics and Cationic Steroid Antibiotics 1 J. Med. Chem. 2002, 45 (3) 663-669
40. Morones, J. R.; Elechiguerra, J. L.; Camacho, A.; Holt, K.; Kouri, J. B.; Ramírez, J. T.; Yacaman, M. J. The Bactericidal Effect of Silver Nanoparticles Nanotechnology 2005, 16 (10) 2346
41. Mahmoudi, M.; Laurent, S.; Shokrgozar, M. A.; Hosseinkhani, M. Toxicity Evaluations of Superparamagnetic Iron Oxide Nanoparticles: Cell "Vision" Versus Physicochemical Properties of Nanoparticles ACS Nano 2011, 5 (9) 7263-7276
42. Laurent, S.; Burtea, C.; Thirifays, C.; Häfeli, U. O.; Mahmoudi, M. Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and "Cell Vision PLoS One 2012, 7 (1) e29997
43. Jain, J.; Arora, S.; Rajwade, J. M.; Omray, P.; Khandelwal, S.; Paknikar, K. M. Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use Mol. Pharmaceutics 2009, 6 (5) 1388-1401.